Clemens Muehlan, PhD

Project Clinical Pharmacologist
Idorsia Pharmaceuticals Ltd, Switzerland

Clemens Muehlan is working as a Project Clinical Pharmacologist at Idorsia Pharmaceuticals Ltd in Allschwil, Switzerland. In his role, Clemens is responsible
for the Phase 1 development of daridorexant, a dual orexin receptor antagonist (DORA). Clemens earned his PhD from the University of Basel, Switzerland. He has published both original research and review papers in the area (early development of a DORA) and has presented his research at international meetings.

Poster(s):

• P-123 - SIMULATED DRIVING PERFORMANCE AFTER BEDTIME ADMINISTRATION OF DARIDOREXANT, A DUAL OREXIN RECEPTOR ANTAGONIST FOR THE TREATMENT OF INSOMNIA.